Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-07-28

FDA Approved: FLUTICASONE PROPIONATE HFA — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

FDA approved a supplemental application for Fluticasone Propionate HFA by Prasco Laboratories, adding a generic inhaled corticosteroid product to the market for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone Propionate HFA (Fluticasone Propionate)

Snippet

SUPPL AP for FLUTICASONE PROPIONATE HFA (FLUTICASONE PROPIONATE)